Memish Z A, Osoba A O, Shibl A M, Mokaddas E, Venkatesh S, Rotimi V O
Department of Infectious Prevention and Control, King Abdulaziz Medical City, King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
J Chemother. 2007 Oct;19(5):471-81. doi: 10.1179/joc.2007.19.5.471.
For many years in the past Streptococcus pneumoniae was uniformly susceptible to penicillin until the sudden and unexpected emergence of clinical infections caused by penicillin-resistant S. pneumoniae (PRSP) in 1967. Within the following decade, reports of nosocomial and community outbreaks of infections due to PRSP became widespread all over the world. Recent reports suggest that the incidence of resistance rates is rising in many countries although there are geographical variations in the prevalence and patterns of resistance between countries. The problem of antibiotic resistance is further compounded by the emergence of resistance to many beta-lactam antibiotics. The first report of PRSP in Saudi Arabia was in 1991. Barely a year after, PRSP infection was reported in Kuwait in 1992. Since then, studies from various parts of these countries have recorded prevalence rates ranging from 6.2% in Riyadh to 34% in Jeddah and 20% to 56% in neighboring Kuwait. These suggest considerable variation in the prevalence of PRSP in different cities in the Saudi Kingdom and Kuwait. The mechanism of resistance is due to chromosomally mediated alteration of penicillin-binding proteins (PBPs), which are target sites for beta-lactam antibiotics. It would appear that the spread of PRSP strains in Saudi Arabia is driven by the selective pressure created by excessive use and misuse of antimicrobial agents made possible by the easy availability of these agents, often frequently obtainable over the counter. In Kuwait, irrational and misguided use of antibiotics may be the major driving force favoring the spread of PRSP. The serotypes of strains encountered in Saudi Arabia and Kuwait are almost identical, with serotypes 19, 6, 15, 14 and 23 being the most common; together they constitute about 70% of the isolates circulating in these countries. In general, almost 90% of the serotypes included in the 23-polyvalent vaccine are present in the general population. However, a much lower percentage of these serotypes is found in the conjugated vaccines, which are more relevant to our communities. This paper reviews the emergence and the steady increase in the prevalence of penicillin-resistant pneumococcal strains in Saudi Arabia and Kuwait during the last 10 years. It discusses the trends, mechanisms of resistance and factors associated with the emergence, dissemination, and colonization of resistant organisms and suggests options available to clinicians for management of infections due to PRSP.
在过去的许多年里,肺炎链球菌一直对青霉素普遍敏感,直到1967年突然意外地出现了由耐青霉素肺炎链球菌(PRSP)引起的临床感染。在接下来的十年里,世界各地关于PRSP引起的医院感染和社区感染暴发的报道越来越多。最近的报告表明,尽管各国之间耐药性的流行情况和模式存在地域差异,但许多国家的耐药率仍在上升。对多种β-内酰胺类抗生素产生耐药性的出现,使抗生素耐药性问题更加复杂。沙特阿拉伯1991年首次报告PRSP。仅仅一年后,1992年科威特报告了PRSP感染。从那时起,这些国家不同地区的研究记录的流行率从利雅得的6.2%到吉达的34%,以及邻国科威特的20%到56%不等。这些表明沙特王国和科威特不同城市PRSP的流行率存在很大差异。耐药机制是由于染色体介导的青霉素结合蛋白(PBPs)改变,PBPs是β-内酰胺类抗生素的靶点。似乎沙特阿拉伯PRSP菌株的传播是由抗菌药物过度使用和滥用造成的选择性压力驱动的,这些药物很容易获得,通常可以在柜台买到。在科威特,不合理和错误使用抗生素可能是促进PRSP传播的主要驱动力。在沙特阿拉伯和科威特遇到的菌株血清型几乎相同,血清型19、6、15、14和23最为常见;它们一起构成了这些国家流通菌株的约70%。一般来说,23价疫苗中的血清型几乎90%存在于普通人群中。然而,在与我们社区更相关的结合疫苗中,这些血清型的比例要低得多。本文回顾了过去10年沙特阿拉伯和科威特耐青霉素肺炎球菌菌株的出现和流行率的稳步上升。讨论了耐药趋势、机制以及与耐药生物体出现、传播和定植相关的因素,并为临床医生提供了治疗PRSP感染的可用选择。